Bottom line
Is UHPSX a good fund? The bottom line
UHPSX is a share class of UltraShort China ProFund, an actively managed leveraged & inverse mutual fund from ProShares.
Annual fees run 2.78% — about $278 a year on every $10,000 invested, more expensive than 99% of leveraged & inverse funds we track.
It returned −22.3% over one year, −32.6% a year over five years, −29.3% a year over ten (as of Dec 31, 2024, per its prospectus).
With $2.2 million in net assets and 9 holdings, its largest position is N/a (29.2%) and the top 10 make up 107.1% of the portfolio.
What to watch
- Expensive for its category (2.78%)
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 107.1% of assets
- 12b-1 marketing fee of 1% a year
- Small fund ($2.2 million) — small funds are likelier to close
Updated Nov 19, 2026
What UHPSX invests in
UltraShort China ProFund (the Fund) seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the S&P China Select ADR Index (USD) (the Index).
The Fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is designed to measure the performance of companies domiciled in China and traded on U.S. exchanges. The Index includes companies that have ADRs, New York Shares, or Global Registered Shares listed on the New York Stock Exchange or Nasdaq Stock Market. Companies are selected if they are domiciled in China and meet certain market capitalization and liquidity requirements. Selected companies are weighted based on market capitalization. The Indexs composition and assigned weights are reevaluated quarterly in March, June, September, and December. The Index is constructed and maintained by S&P Dow Jones Indices LLC. More information about the Index can be found using the Bloomberg ticker symbol BKTCN. Under normal circumstances…
From the fund's prospectus (filed Nov 25, 2025).
UHPSX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| UHPSX | −22.3% | −32.6% | −29.3% |
| Leveraged & Inverse median | −7.7% | −11.8% | −13.5% |
Source: Fund prospectus, as of Dec 31, 2024
What UHPSX costs
On a $10,000 investment, UHPSX's 2.78% expense ratio costs about $278 a year. The prospectus estimates $4,115 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.
UHPSX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | N/a | 29.18% |
| 2 | N/a | 22.44% |
| 3 | N/a | 17.95% |
| 4 | N/a | 17.95% |
| 5 | N/a | 14.09% |
| 6 | N/a | 5.34% |
| 7 | N/a | 0.09% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 107.1% of the fund. See all top 25 holdings and asset mix →